Summary & Overview
HCPCS P9017: Fresh Frozen Plasma (Single Donor), Frozen Within 8 Hours
HCPCS Level II code P9017 identifies a unit of fresh frozen plasma (single donor) frozen within eight hours of collection, a blood product used to replace coagulation factors in patients with bleeding, coagulation disorders, or during massive transfusion. Nationally, accurate coding for plasma units matters for clinical documentation, inventory management, and reimbursement across acute and outpatient transfusion settings.
Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical service represented by P9017, typical sites of care where the product is administered, and which payers commonly cover such blood products. The publication outlines the billing context for this biologic product and presents benchmarks and policy-relevant considerations such as coding alignment, coverage patterns, and documentation expectations.
This summary provides operational and policy-oriented context for providers, revenue cycle managers, and payers seeking clarity on reporting and tracking units of fresh frozen plasma frozen within eight hours. Data not available in the input will be noted in detailed sections.
Billing Code Overview
HCPCS Level II code P9017 describes fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit. This HCPCS Level II code is used to report provision of a single unit of fresh frozen plasma collected from one donor and frozen within eight hours to preserve coagulation factors.
Service Type: Blood product transfusion / biologic blood component
Typical Site of Service: Hospital inpatient or outpatient, emergency department, ambulatory infusion center, or other facility-based transfusion settings
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with chronic liver disease is admitted to the inpatient medical unit for acute gastrointestinal bleeding and develops coagulopathy with an elevated INR and evidence of active bleeding. The transfusion service evaluates laboratory values (e.g., INR, PT, fibrinogen) and orders plasma to correct clotting factor deficiencies prior to endoscopy. A unit of P9017 (fresh frozen plasma, single donor, frozen within 8 hours of collection, each unit) is requested from the blood bank.
The clinical workflow: laboratory identifies abnormal coagulation studies and communicates with the primary team; an order for P9017 is placed in the electronic medical record with indication and transfusion consent documented; the blood bank issues thawed plasma per institutional transfusion protocol; bedside nursing verifies patient identity, obtains baseline vitals, and initiates transfusion under monitoring for transfusion reactions; post-transfusion labs reassess INR and clinical bleeding status. Typical sites of service include inpatient hospital medical/surgical units, intensive care units, and operating rooms where rapid correction of coagulopathy is needed. Emergency department use occurs when immediate reversal of coagulopathy is required for acute hemorrhage or before urgent procedures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |